Healthcare Value Capital as of Sept. 30, 2016
Portfolio Holdings for Healthcare Value Capital
Healthcare Value Capital holds 18 positions in its portfolio as reported in the September 2016 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Biosante Pharmaceuticals (ANIP) | 26.3 | $17M | 250k | 66.36 | |
| DepoMed | 13.8 | $8.7M | 350k | 24.97 | |
| Pfizer (PFE) | 9.4 | $5.9M | 175k | 33.87 | |
| Quest Diagnostics Incorporated (DGX) | 8.9 | $5.6M | 66k | 84.63 | |
| D Albany Molecular Res Earch Inc Common Stock 0 | 7.9 | $5.0M | 302k | 16.51 | |
| Gilead Sciences (GILD) | 7.5 | $4.7M | 60k | 79.12 | |
| Qlt | 7.0 | $4.4M | 2.2M | 2.06 | |
| Aralez Pharmaceuticals | 4.4 | $2.8M | 575k | 4.85 | |
| CryoLife (AORT) | 4.2 | $2.6M | 150k | 17.57 | |
| AMAG Pharmaceuticals | 2.9 | $1.8M | 75k | 24.51 | |
| Amarin Corporation (AMRN) | 2.3 | $1.4M | 450k | 3.19 | |
| Cytokinetics (CYTK) | 1.4 | $918k | 100k | 9.18 | |
| Ultra Short Russell 2000 | 1.1 | $721k | 25k | 28.84 | |
| Sunesis Pharmaceuticals Inc Ne | 1.0 | $656k | 150k | 4.37 | |
| Kite Pharma | 0.8 | $480k | 8.6k | 55.81 | |
| Zogenix | 0.6 | $364k | 32k | 11.43 | |
| Apricus Bioscience | 0.2 | $150k | 440k | 0.34 | |
| Fibrocell Science | 0.2 | $106k | 148k | 0.72 |
